Filing Details

Accession Number:
0000784199-23-000052
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-01 18:41:45
Reporting Period:
2023-02-23
Accepted Time:
2023-03-01 18:41:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
784199 Artivion Inc. AORT Surgical & Medical Instruments & Apparatus (3841) 592417093
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1850597 L. Rochelle Maney 1655 Roberts Blvd., Nw
Kennesaw GA 30144
Vp, Quality No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-23 2,356 $0.00 25,895 No 4 A Direct
Common Stock Disposition 2023-02-27 878 $12.94 25,017 No 4 S Direct
Common Stock Acquisiton 2023-02-23 4,240 $0.00 29,257 No 4 A Direct
Common Stock Disposition 2023-02-27 790 $12.94 28,467 No 4 A Direct
Common Stock Disposition 2023-02-28 406 $13.24 28,061 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 A Direct
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.
  2. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
  3. Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.
  4. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.